IE
UROV

Israel Englander’s Urovant Sciences Ltd. UROV Stock Holding History

Israel Englander’s Portfolio UROV Stock Details UROV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-34,578
Closed -$340K – 5004
2020
Q2 		$340K Buy
+34,578
New +$332K ﹤0.01% 3610
2020
Q1 		– Sell
-16,970
Closed -$263K – 4802
2019
Q4 		$263K Sell
16,970
-22,415
-57% -$243K ﹤0.01% 3731
2019
Q3 		$372K Sell
39,385
-399,526
-91% -$3.47M ﹤0.01% 3446
2019
Q2 		$3.47M Sell
438,911
-100,978
-19% -$828K 0.01% 2064
2019
Q1 		$5.43M Buy
539,889
+136,239
+34% +$1.4M 0.01% 1695
2018
Q4 		$2.66M Sell
403,650
-91,114
-18% -$829K ﹤0.01% 2023
2018
Q3 		$5.94M Buy
+494,764
New +$5.85M 0.01% 1679

Other funds holding UROV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Israel Englander's UROV Position: Q3 2020 in Review

Israel Englander sold out of Urovant Sciences Ltd. (UROV) in Q3 2020, closing a stake of 34,578 shares — an estimated $340K sold.

Israel Englander first reported a position in UROV in Q3 2018 and held it in 7 quarters. The position peaked at $5.94M in Q3 2018. 23 funds tracked by Wall St. Rank hold UROV as of Q3 2020.

  • Israel Englander reported no remaining Urovant Sciences Ltd. position as of Q3 2020 after selling out during the quarter.
  • Israel Englander sold 34,578 Urovant Sciences Ltd. shares in Q3 2020, an estimated $340K.
  • Israel Englander first reported a position in Urovant Sciences Ltd. in Q3 2018 and held it in 7 quarters.
  • Israel Englander's Urovant Sciences Ltd. position peaked at $5.94M in Q3 2018.
  • 23 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q3 2020.

Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.